+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

mTORC-1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

mTORC-1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Caspases Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Caspases Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Beta-3 Receptors Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Beta-3 Receptors Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
ATPase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

ATPase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
20s Proteasome Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

20s Proteasome Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Galectin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Galectin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
TIM-3 Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

TIM-3 Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Apoptosis Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Apoptosis Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
G2 Checkpoint Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

G2 Checkpoint Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Gamma Secretase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Gamma Secretase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Heat shock protein inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Heat shock protein inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD 3 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 3 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024 - Product Thumbnail Image

Glucocorticoid induced tumor necrosis factor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Sphingosine 1-Phosphate (S1P) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
PI3K inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

PI3K inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more